About
Overview
Leadership Team
Board of Directors
Investors
History
Contact
Innovation
Capsida Approach
Capsid Engineering
Discovery & Preclinical
GMP Manufacturing Operations
Clinical Development
Pipeline
Overview
CAP-002: STXBP1
CAP-003: GBA
CAP-004: FA
Patients
Overview
STXBP1 Developmental and Epileptic Encephalopathy
Reece’s Story
Parkinson’s Disease Associated with GBA Mutations
Friedreich’s Ataxia
News
Press Releases
Community Updates
Publications
Careers
Culture & Benefits
Current Opportunities
Company Updates
Show all
community-letter
Company Updates
An Important Update Regarding Our CAP-002 Program: A Letter to the STXBP1 Community
January 8, 2026
A Letter to the STXBP1 Community
September 10, 2025
Privacy Preference Center
Privacy Preferences
